Department of Pathology, BC Cancer Vancouver Centre, 600 West 10th Avenue, Vancouver, British Columbia, V5Z 1H5, Canada.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Virchows Arch. 2019 Mar;474(3):333-339. doi: 10.1007/s00428-018-02515-3. Epub 2019 Jan 4.
Metastatic breast carcinoma to the urinary bladder is rare. Eleven cases of metastatic breast carcinoma to the bladder are described in this report, including one case with a tumor to tumor metastasis. The patients ranged from 51 to 83 years of age. The time intervals between the diagnosis of primary breast cancer and the occurrence of bladder metastases ranged from 41 to 336 months. There were seven cases of invasive ductal carcinoma and four cases of invasive lobular carcinoma. In one case, a lobular carcinoma of the breast metastasized to a concurrent squamous cell carcinoma of the bladder. The immunophenotypic status of estrogen receptor and Her2 expression of the metastatic carcinomas were all concordant with the primary tumors. In nine patients with follow-up available, seven patients died of the disease ranging from 1 to 23 months after the diagnosis of the bladder metastasis and two patients were alive at 5 months of follow-up. To date, this report is the largest single series of patients with breast carcinoma metastatic to the bladder. It is the first reported instance of lobular carcinoma of the breast metastasizing to a squamous cell carcinoma of the bladder.
膀胱癌转移性乳腺癌较为罕见。本报告描述了 11 例膀胱癌转移性乳腺癌病例,包括 1 例肿瘤对肿瘤转移病例。患者年龄 51-83 岁。原发性乳腺癌和膀胱癌转移之间的时间间隔为 41-336 个月。其中 7 例为浸润性导管癌,4 例为浸润性小叶癌。有 1 例乳腺癌小叶癌转移至同时发生的膀胱鳞状细胞癌。转移性癌的雌激素受体和 Her2 表达的免疫表型状态均与原发性肿瘤一致。在有随访资料的 9 例患者中,7 例患者在诊断膀胱癌转移后 1-23 个月内死于该疾病,2 例患者在随访 5 个月时仍存活。迄今为止,本报告是关于膀胱癌转移性乳腺癌患者的最大单一系列病例。这也是首例报道的乳腺癌小叶癌转移至膀胱鳞状细胞癌的病例。